Publicaciones en colaboración con investigadores/as de Universidad Autónoma de Madrid (26)

2019

  1. Antibody responses to influenza vaccine in patients on biological therapy: Results of RIER cohort study

    Medicina Clinica, Vol. 153, Núm. 10, pp. 380-386

  2. Choroidal and retinal thickness in systemic autoimmune and inflammatory diseases: A review

    Survey of Ophthalmology, Vol. 64, Núm. 6, pp. 757-769

  3. Genetic variation at the glycosaminoglycan metabolism pathway contributes to the risk of psoriatic arthritis but not psoriasis

    Annals of the Rheumatic Diseases, Vol. 78, Núm. 3, pp. 355-364

  4. Long-term pulmonary outcomes and mortality in idiopathic inflammatory myopathies associated with interstitial lung disease

    Clinical Rheumatology, Vol. 38, Núm. 3, pp. 803-815

  5. Visual acuity loss and development of ocular complications in white dot syndromes: a longitudinal analysis of 3 centers

    Graefe's Archive for Clinical and Experimental Ophthalmology, Vol. 257, Núm. 11, pp. 2505-2516

2017

  1. Development of an activity disease score in patients with uveitis (UVEDAI)

    Rheumatology International, Vol. 37, Núm. 4, pp. 647-656

  2. Incidence, associated factors and clinical impact of severe infections in a large, multicentric cohort of patients with systemic lupus erythematosus

    Seminars in Arthritis and Rheumatism, Vol. 47, Núm. 1, pp. 38-45

  3. SCORE study: quality indicators for rheumatology nursing clinics

    Rheumatology International, Vol. 37, Núm. 3, pp. 353-361

  4. The effect of smoking on clinical and structural damage in patients with axial spondyloarthritis: A systematic literature review

    Seminars in Arthritis and Rheumatism, Vol. 46, Núm. 5, pp. 569-583

2016

  1. Multidisciplinary dermatology–rheumatology management for patients with moderate-to-severe psoriasis and psoriatic arthritis: a systematic review

    Rheumatology International, Vol. 36, Núm. 2, pp. 221-229

  2. Relationship between damage clustering and mortality in systemic lupus erythematosus in early and late stages of the disease: Cluster analyses in a large cohort from the Spanish Society of Rheumatology Lupus Registry

    Rheumatology (United Kingdom), Vol. 55, Núm. 7, pp. 1243-1250

2015

  1. A deletion at adamts9-magi1 locus is associated with psoriatic arthritis risk

    Annals of the Rheumatic Diseases, Vol. 74, Núm. 10, pp. 1875-1881

2014

  1. Efficacy and safety of rituximab in the treatment of non-renal systemic lupus erythematosus: A systematic review

    Seminars in Arthritis and Rheumatism, Vol. 44, Núm. 2, pp. 175-185

  2. PDE3A-SLCO1C1 locus is associated with response to anti-tumor necrosis factor therapy in psoriatic arthritis

    Pharmacogenomics, Vol. 15, Núm. 14, pp. 1763-1769

  3. Performance of the Assessment of Spondyloarthritis International Society criteria for the classification of spondyloarthritis in early spondyloarthritis clinics participating in the ESPERANZA programme

    Rheumatology (United Kingdom), Vol. 53, Núm. 2, pp. 353-360

  4. Validity of the Ankylosing Spondylitis Disease Activity Score (ASDAS) in patients with early spondyloarthritis from the Esperanza programme

    Annals of the Rheumatic Diseases, Vol. 73, Núm. 7, pp. 1350-1355

2011

  1. A model for the development and implementation of a national plan for the optimal management of early spondyloarthritis: The Esperanza Program

    Annals of the Rheumatic Diseases, Vol. 70, Núm. 5, pp. 827-830

2006

  1. Uveitis

    Best Practice and Research: Clinical Rheumatology, Vol. 20, Núm. 3, pp. 487-505

2003

  1. Argumentos a favor de que la mejor opción es la gastroprotección para evitar las recidivas de las úlceras y sus complicaciones producidas por los AINE convencionales

    Seminarios de la Fundacion Espanola de Reumatologia, Vol. 4, Núm. 2, pp. 49-56

  2. Sulfasalazine reduces the number of flares of acute anterior uveitis over a one-year period

    Journal of Rheumatology, Vol. 30, Núm. 6, pp. 1277-1279